Abstract:
The present invention is to efficiently and simply prepare an optically active 7-substituted-2-aminotetralin with industrial advantage. In the process, a 7-substituted-2-tetralone or its bisulfite adduct is reduced with a microorganism to an optically active 7-substituted-2-tetralol. Then, a sulfonyl group is introduced to the hydroxy group to form an optically active 7-substituted-2-sulfonyloxytetralin. Then, with inversion of the configuration, a nitrogen substituent is introduced using a nitrogen nucleophile to form an optically active 2,7-substituted tetralin. Furthermore, if necessary, the nitrogen substituent is converted into a non-substituted amino group. Thus, an optically active 7-substituted-2-aminotetralin or its salt is prepared.
Abstract:
The invention relates to simple and efficient preparation of optically active 7-substituted-2-aminotetralins with industrial advantage. A process for preparation of optically active 7- substituted-2-aminotetralins or salts thereof, which comprises reducing a 7-substituted-2-tetralone or a bisulfite adduct thereof with a microorganism into an optically active 7-substituted-2-tetralol, introducing a sulfonyl group into the hydroxyl group of the tetralol to obtain an optically active 7-substituted-2-sulfonyloxytetralin, introducing a nitrogen substituent into the resulting tetralin by the use of a nitrogen nucleophile through inversion to obtain an optically active 2,7-substituted tetralin, and, if necessary, converting the nitrogen substituent into an unsubstituted amino group.
Abstract:
PROBLEM TO BE SOLVED: To provide an affinity carrier for removing or purifying a protein or a peptide having the Kringle sequence, including a plasminogen, and to provide a method for removing or purifying the protein or peptide having the Kringle sequence using the affinity carrier.SOLUTION: The protein or peptide having the Kringle sequence can efficiently be removed and purified with the affinity carrier which is obtained by bringing an activated carrier into contact with lysine at pH≤9 and contains the lysine immobilized therein. Furthermore, there is provided the method for purifying and removing the protein or peptide having the Kringle sequence using the affinity carrier.
Abstract:
PROBLEM TO BE SOLVED: To provide in large quantity and in a stable quality a column packing agent where a protein and molecules having functions different from those of the protein are immobilized in an activated porous carrier.SOLUTION: The column packing agent wherein the protein and molecules having functions different from those of the protein are immobilized in a porous carrier are prepared with stable quality, even in case of preparing a large quantity of the packing agent, when the protein and the molecules having functions different from those of the protein are immobilized in the porous carrier, by conducting a continuous one-pot reaction even when the replacing operation of the reaction liquid is skipped during the immobilizing reaction.
Abstract:
PROBLEM TO BE SOLVED: To provide a process for efficiently and readily producing an optically active 7-substituted-2-aminotetralin, with industrial advantage. SOLUTION: The process for the preparation of an optically active 7-substituted-2-aminotetralin or its salt includes reduction of a 7-substituted-2-tetralone or a bisulfite adduct thereof, with a microorganism into an optically active 7-substituted-2-tetralol; introduction of a sulfonyl group into the hydroxyl group of the tetralol, to obtain an optically active 7-substituted-2-sulfonyloxytetralin; introduction of a nitrogen substituent into the resulting tetralin by the use of a nitrogen nucleophile through steric inversion, to obtain an optically active 2,7-substituted tetralin; and if necessary, the conversion of the nitrogen substituent into an unsubstituted amino group. COPYRIGHT: (C)2009,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To provide an adsorbent that can efficiently adsorb and remove PCSK9 in body fluid, and to provide an adsorber.SOLUTION: The adsorbent 3 of the PCSK9 includes a water insoluble carrier having an anionic functional group. Moreover, the adsorber 7 of the PCSK9 is filled with the adsorbent 3 of the PCSK9 in a container with a liquid inlet 1 and a liquid outlet 2 and a flowout prevention means 5 for preventing the adsorbent 3 from flowing out the container.
Abstract:
PROBLEM TO BE SOLVED: To provide a column for obtaining purification efficiency of BL-angiostatin equal to or more than a sepharose system carrier in a carrier other than the sepharose system carrier.SOLUTION: An affinity trap reactor can suppress generation of excessive resolvent by dividing into two kinds of carriers in which enzyme and a molecule with affinity for the resolvent by the enzyme are individually immobilized, and having the column in order of enzyme reaction and condensation of the resolvent by the enzyme.